Evidence map›Paper›PMID 37040403›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Two-step devitrification of ultrastable glasses.

Cecilia Herrero, Camille Scalliet, M D Ediger, Ludovic Berthier

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The journal of physical chemistry letters · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cecilia HerreroLaboratoire Charles Coulomb (L2C), Université de Montpellier, CNRS, Montpellier 34095, France.ORCID 0000-0002-7569-2684
Camille ScallietDepartment of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge CB3 0WA, United Kingdom.ORCID 0000-0002-7969-891X
M D EdigerDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706.ORCID 0000-0003-4715-8473
Ludovic BerthierLaboratoire Charles Coulomb (L2C), Université de Montpellier, CNRS, Montpellier 34095, France.ORCID 0000-0003-2059-702X

Funding

Agence Nationale de la Recherche (ANR) ANR-16-IDEX-0006EC | ERC | HORIZON EUROPE European Research Council (ERC) 740269Leverhulme Trust VP1-2019-029National Science Foundation (NSF) CHE-2153944Simons Foundation (SF) 454933
6 · The paper itself

Abstract

The discovery of ultrastable glasses raises novel challenges about glassy systems. Recent experiments studied the macroscopic devitrification of ultrastable glasses into liquids upon heating but lacked microscopic resolution. We use molecular dynamics simulations to analyze the kinetics of this transformation. In the most stable systems, devitrification occurs after a very large time, but the liquid emerges in two steps. At short times, we observe the rare nucleation and slow growth of isolated droplets containing a liquid maintained under pressure by the rigidity of the surrounding glass. At large times, pressure is released after the droplets coalesce into large domains, which accelerates devitrification. This two-step process produces pronounced deviations from the classical Avrami kinetics and explains the emergence of a giant lengthscale characterizing the devitrification of bulk ultrastable glasses. Our study elucidates the nonequilibrium kinetics of glasses following a large temperature jump, which differs from both equilibrium relaxation and aging dynamics, and will guide future experimental studies.

Indexed as

computational methodsdevitrificationglasssupercooled liquid

Identifiers

PMID37040403
PMCPMC10120036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.